학술논문

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Document Type
Article
Source
Blood; December 2016, Vol. 128 Issue: 22 p69-69, 1p
Subject
Language
ISSN
00064971; 15280020
Abstract
Lindsley: Takeda Pharmaceuticals: Consultancy; MedImmune: Research Funding. Mar:H3 Biomedicine: Other: Spouse's employment.